Teton Capital takes stake in Atlantic Union, urges for changes, Bloomberg says
Confident Investing Starts Here:
Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Insider
an hour ago
- Business Insider
Tesla (TSLA) Gets a Buy from Piper Sandler
In a report released today, Alexander Potter from Piper Sandler maintained a Buy rating on Tesla, with a price target of $400.00. The company's shares closed last Friday at $302.63. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. According to TipRanks, Potter is a 5-star analyst with an average return of 18.7% and a 47.67% success rate. Potter covers the Consumer Cyclical sector, focusing on stocks such as Tesla, Ford Motor, and Carvana Co. In addition to Piper Sandler, Tesla also received a Buy from Morgan Stanley's Adam Jonas in a report issued today. However, on July 31, Wolfe Research reiterated a Hold rating on Tesla (NASDAQ: TSLA). Based on Tesla's latest earnings release for the quarter ending June 30, the company reported a quarterly revenue of $22.5 billion and a net profit of $1.17 billion. In comparison, last year the company earned a revenue of $25.5 billion and had a net profit of $1.4 billion Based on the recent corporate insider activity of 51 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of TSLA in relation to earlier this year. Most recently, in June 2025, Xiaotong Zhu, the SVP, APAC of TSLA sold 15,000.00 shares for a total of $4,857,000.00.
Business Insider
2 hours ago
- Business Insider
Evercore ISI Sticks to Their Buy Rating for Amazon (AMZN)
In a report released on August 1, Mark Mahaney from Evercore ISI maintained a Buy rating on Amazon, with a price target of $280.00. The company's shares closed last Friday at $214.75. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. According to TipRanks, Mahaney is a 5-star analyst with an average return of 14.3% and a 58.16% success rate. Mahaney covers the Communication Services sector, focusing on stocks such as Alphabet Class A, Meta Platforms, and Netflix. In addition to Evercore ISI, Amazon also received a Buy from TR | OpenAI – 4o's Rina Curatex in a report issued yesterday. However, on August 1, Wells Fargo reiterated a Hold rating on Amazon (NASDAQ: AMZN).
Business Insider
11 hours ago
- Business Insider
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (RMD) Receives a Buy from Citi
Citi analyst Mathieu Chevrier maintained a Buy rating on Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per today and set a price target of A$49.00. The company's shares opened today at A$43.01. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Chevrier covers the Healthcare sector, focusing on stocks such as Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per Ansell, and Fisher & Paykel Healthcare Corporation Limited. According to TipRanks, Chevrier has an average return of -3.5% and a 41.18% success rate on recommended stocks. Currently, the analyst consensus on Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per is a Strong Buy with an average price target of A$45.18, a 5.05% upside from current levels. In a report released on August 1, Wilsons also upgraded the stock to a Buy with a A$43.50 price target. Based on Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per latest earnings release for the quarter ending March 31, the company reported a quarterly revenue of A$1.29 billion and a net profit of A$365.04 million. In comparison, last year the company earned a revenue of A$1.2 billion and had a net profit of A$300.49 million
